NCT05235217View on ClinicalTrials.gov

Bioequivalence Study of Esomeprazole in Healthy Adult Subjects Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions
Bioequivalence
Interventions
DRUG

Test product (T) 40 mg Hard Gelatin Capsules

Hard Gelatin Capsules products containing 40 mg Esomeprazole

DRUG

Reference product (R) 40 mg Hard Gelatin Capsules

Reference product (R) 40 mg Hard Gelatin Capsules

Trial Locations (1)

Unknown

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER